• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Funds

LeapFrog raises $700m Emerging Markets Fund III

  • Katharine Hidalgo
  • Katharine Hidalgo
  • 10 May 2019
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Impact investor LeapFrog has surpassed its $600m target to raise $700m for LeapFrog Emerging Markets Fund III.

This marks an increase on the volume of its predecessor fund LeapFrog Emerging Markets Fund II, which raised $400m in 2014. The firm's debut fund closed on $135m in 2009.

LeapFrog has invested in 26 businesses since its inception. Its latest fundraise will take the firm to $1.6bn in total commitments.

LeapFrog Emerging Markets Fund III

  • Target:

    $600m

  • Closed on:

    $700m, May 2019

  • Focus:

    Healthcare, financial services

  • Fund manager:

    LeapFrog Investments

Cebile Capital acted as placement agent to the fundraise.

Investors
Prudential Financial, Overseas Private Investment Corporation and IFC acted as lead investors. The fund drew insurance companies, pension funds, asset managers, development financiers, corporations and foundations as LPs.

Insurance companies investing in the fund included Admiral, AIG, Axa XL, Everest Re, Hannover Re, Prudential Financial, QBE and Zurich.

Pensions and asset managers such as US-based Ascension Capital, Pinebridge and TIAA-Nuveen, European investors Kempen, Partners Group Impact, Stiftung Abendrot and SBZ, and Australia-based Christian Super and Hesta also invested.

Germany-based DEG, IFC and France-based Proparco are some of the development financiers invested in the fund.

Merck & Co, as well as foundations including PactWorld, the Ford Foundation and the Rockefeller Foundation, also invested.

Investments
LeapFrog Emerging Markets III invests in healthcare and financial services companies in emerging markets such as Africa and Asia. The firm typically writes equity tickets of $10-50m.

The new fund has already made investments in five companies: UK-based remittances provider WorldRemit, unsecured credit provider NeoGrowth, healthcare provider Goodlife Pharmacy, medical products distributor Pyramid Pharma and orthopaedic products producer Ascent Meditech.

Previously, LeapFrog has invested in Sweden-based life insurance provider Bima and UK-based software company Striva.

People
LeapFrog Investments – Andrew Kuper (founder, CEO); Nick Moon (partner, head, investor relations).
Prudential Financial – Charles Lowrey (chairman, chief executive officer).
Overseas Private Investment Corporation – David Bohigian (acting president, CEO).
IFC – Philippe Le Houérou (CEO).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Funds
  • Venture
  • UK / Ireland
  • Social Impact
  • Emerging Markets
  • IFC (World Bank)

More on Funds

Fund closes in US dollars
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • Funds
  • 05 September 2023
Bettina Curtze of Redalpine
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
Andris K. Berzins of Change Ventures
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • Funds
  • 31 August 2023
Fund launches in euros
Iron Wolf Capital targets EUR 70m for second vehicle

Baltic investor anticipates early 2024 launch and will focus on early-stage AI and deeptech startups

  • Funds
  • 30 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013